1
|
Werner M, Pampel J, Pham TL, Thomas F. Late-Stage Functionalisation of Peptides on the Solid Phase by an Iodination-Substitution Approach. Chemistry 2022; 28:e202201339. [PMID: 35700354 PMCID: PMC9545490 DOI: 10.1002/chem.202201339] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2022] [Indexed: 11/20/2022]
Abstract
The functionalisation of peptides at a late synthesis stage holds great potential, for example, for the synthesis of peptide pharmaceuticals, fluorescent biosensors or peptidomimetics. Here we describe an on-resin iodination-substitution reaction sequence on homoserine that is also suitable for peptide modification in a combinatorial format. The reaction sequence is accessible to a wide range of sulfur nucleophiles with various functional groups including boronic acids, hydroxy groups or aromatic amines. In this way, methionine-like thioethers or thioesters and thiosulfonates are accessible. Next to sulfur nucleophiles, selenols, pyridines and carboxylic acids were successfully used as nucleophiles, whereas phenols did not react. The late-stage iodination-substitution approach is not only applicable to short peptides but also to the more complex 34-amino-acid WW domains. We applied this strategy to introduce 7-mercapto-4-methylcoumarin into a switchable ZnII responsive WW domain to design an iFRET-based ZnII sensor.
Collapse
Affiliation(s)
- Marius Werner
- Institute of Organic ChemistryHeidelberg UniversityIm Neuenheimer Feld 27069120HeidelbergGermany
- Centre for Advanced Materials (CAM)Heidelberg UniversityIm Neuenheimer Feld 22569120HeidelbergGermany
- Department of Medicinal ChemistryInstitute of Pharmacy and Molecular Biotechnology (IPMB)Heidelberg UniversityIm Neuenheimer Feld 36469120HeidelbergGermany
| | - Julius Pampel
- Department of Chemical BiologyMax Planck Institute for Medical ResearchJahnstraße 2969120HeidelbergGermany
| | - Truc Lam Pham
- Institute of Organic ChemistryHeidelberg UniversityIm Neuenheimer Feld 27069120HeidelbergGermany
- Centre for Advanced Materials (CAM)Heidelberg UniversityIm Neuenheimer Feld 22569120HeidelbergGermany
| | - Franziska Thomas
- Institute of Organic ChemistryHeidelberg UniversityIm Neuenheimer Feld 27069120HeidelbergGermany
- Centre for Advanced Materials (CAM)Heidelberg UniversityIm Neuenheimer Feld 22569120HeidelbergGermany
| |
Collapse
|
2
|
Hampe L, Harris PWR, Rushton B, Radjainia M, Brimble MA, Mitra AK. Engineering a stable complex of
ERp44
with a designed peptide ligand for analyzing the mode of interaction of
ERp44
with its clients. Pept Sci (Hoboken) 2021. [DOI: 10.1002/pep2.24230] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Lutz Hampe
- School of Biological Sciences The University of Auckland Auckland New Zealand
| | - Paul W. R. Harris
- School of Biological Sciences The University of Auckland Auckland New Zealand
- School of Chemical Sciences The University of Auckland Auckland New Zealand
| | - Ben Rushton
- School of Biological Sciences The University of Auckland Auckland New Zealand
- Bernhard‐Nocht Institute for Tropical Medicine Bernhard‐Nocht‐Straße 74, 20359 Hamburg Germany
| | - Mazdak Radjainia
- School of Biological Sciences The University of Auckland Auckland New Zealand
- Thermo Fisher Scientific Eindhoven The Netherlands
| | - Margaret A. Brimble
- School of Biological Sciences The University of Auckland Auckland New Zealand
- School of Chemical Sciences The University of Auckland Auckland New Zealand
| | - Alok K. Mitra
- School of Biological Sciences The University of Auckland Auckland New Zealand
| |
Collapse
|
3
|
Waliczek M, Pehlivan Ö, Stefanowicz P. A photochemical transformation of cyclic peptides leading to formation of selenolanthionine bridges. NEW J CHEM 2020. [DOI: 10.1039/d0nj01563f] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Peptides with diselenide bridge under UV irradiation eliminate one selenium atom forming selenoether bond with good yield.
Collapse
Affiliation(s)
| | - Özge Pehlivan
- Faculty of Chemistry
- University of Wrocław
- 50-383 Wrocław
- Poland
| | | |
Collapse
|
4
|
Gleeson EC, Wang ZJ, Robinson SD, Chhabra S, MacRaild CA, Jackson WR, Norton RS, Robinson AJ. Stereoselective synthesis and structural elucidation of dicarba peptides. Chem Commun (Camb) 2016; 52:4446-9. [PMID: 26892179 DOI: 10.1039/c5cc10540d] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A facile stereoselective synthesis of cis and trans unsaturated dicarba peptides has been established using preformed diaminosuberic acid derivatives as bridging units. In addition, characteristic spectral differences in the (13)C-NMR spectra of the cis- and trans-isomers show that the chemical shift of carbons in the Δ4,5-diaminosuberic acid residue can be used to assign stereochemistry in unsaturated dicarba peptides formed from ring closing metathesis of linear peptide sequences.
Collapse
Affiliation(s)
- Ellen C Gleeson
- School of Chemistry, Monash University, Clayton 3800, Victoria, Australia.
| | - Zhen J Wang
- School of Chemistry, Monash University, Clayton 3800, Victoria, Australia.
| | - Samuel D Robinson
- Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville 3052, Victoria, Australia
| | - Sandeep Chhabra
- Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville 3052, Victoria, Australia
| | - Christopher A MacRaild
- Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville 3052, Victoria, Australia
| | - W Roy Jackson
- School of Chemistry, Monash University, Clayton 3800, Victoria, Australia.
| | - Raymond S Norton
- Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville 3052, Victoria, Australia
| | - Andrea J Robinson
- School of Chemistry, Monash University, Clayton 3800, Victoria, Australia.
| |
Collapse
|
5
|
Reille-Seroussi M, Gaucher JF, Desole C, Gagey-Eilstein N, Brachet F, Broutin I, Vidal M, Broussy S. Vascular Endothelial Growth Factor Peptide Ligands Explored by Competition Assay and Isothermal Titration Calorimetry. Biochemistry 2015. [DOI: 10.1021/acs.biochem.5b00722] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
| | | | | | | | | | | | - Michel Vidal
- UF Pharmacocinétique
et Pharmacochimie, hôpital Cochin, AP-HP, 27 rue du Faubourg Saint Jacques, Paris 75014, France
| | | |
Collapse
|
6
|
Pulka-Ziach K, Pavet V, Chekkat N, Estieu-Gionnet K, Rohac R, Lechner MC, Smulski CR, Zeder-Lutz G, Altschuh D, Gronemeyer H, Fournel S, Odaert B, Guichard G. Thioether analogues of disulfide-bridged cyclic peptides targeting death receptor 5: conformational analysis, dimerisation and consequences for receptor activation. Chembiochem 2014; 16:293-301. [PMID: 25487639 DOI: 10.1002/cbic.201402485] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2014] [Indexed: 12/31/2022]
Abstract
Cyclic peptides containing redox-stable thioether bridges might provide a useful alternative to disulfide-bridged bioactive peptides. We report the effect of replacing the disulfide bridge with a lanthionine linkage in a 16-mer cyclic peptide that binds to death receptor 5 (DR5, TRAIL-R2). Upon covalent oligomerisation, the disulfide-bridged peptide has previously shown similar behaviour to that of TNF-related apoptosis inducing ligand (TRAIL), by selectively triggering the DR5 cell death pathway. The structural and biological properties of the DR5-binding peptide and its desulfurised analogue were compared. Surface plasmon resonance (SPR) data suggest that these peptides bind DR5 with comparable affinities. The same holds true for dimeric versions of these peptides: the thioether is able to induce DR5-mediated apoptosis of BJAB lymphoma and tumorigenic BJELR cells, albeit to a slightly lower extent compared to its disulfide homologue. NMR analysis revealed subtle variation in the conformations of the two peptides and suggests that the thioether peptide is slightly less folded than its disulfide homologue. These observations could account for the different capability of the two dimers to cluster DR5 receptors on the cell surface and to trigger apoptosis. Nevertheless, our results suggest that the thioether peptide is a potential candidate for evaluation in animal models.
Collapse
Affiliation(s)
- Karolina Pulka-Ziach
- Université de Bordeaux, CNRS, Institut Polytechnique de Bordeaux, UMR5248 CBMN, Institut Européen de Chimie et Biologie, 2 rue Robert Escarpit, 33607 Pessac (France); Present address: Faculty of Chemistry, University of Warsaw, Pasteura 1, 02-093 Warsaw (Poland)
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Aoki K, Maeda M, Nakae T, Okada Y, Ohya K, Chiba K. A disulfide bond replacement strategy enables the efficient design of artificial therapeutic peptides. Tetrahedron 2014. [DOI: 10.1016/j.tet.2014.05.079] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
8
|
de Araujo AD, Mobli M, King GF, Alewood PF. Cyclization of Peptides by using Selenolanthionine Bridges. Angew Chem Int Ed Engl 2012; 51:10298-302. [DOI: 10.1002/anie.201204229] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2012] [Revised: 07/30/2012] [Indexed: 01/01/2023]
|
9
|
de Araujo AD, Mobli M, King GF, Alewood PF. Cyclization of Peptides by using Selenolanthionine Bridges. Angew Chem Int Ed Engl 2012. [DOI: 10.1002/ange.201204229] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
10
|
Dekan Z, Vetter I, Daly NL, Craik DJ, Lewis RJ, Alewood PF. α-Conotoxin ImI Incorporating Stable Cystathionine Bridges Maintains Full Potency and Identical Three-Dimensional Structure. J Am Chem Soc 2011; 133:15866-9. [DOI: 10.1021/ja206408q] [Citation(s) in RCA: 77] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Affiliation(s)
- Zoltan Dekan
- Institute for Molecular Bioscience, The University of Queensland, St Lucia 4072, Queensland, Australia
| | - Irina Vetter
- Institute for Molecular Bioscience, The University of Queensland, St Lucia 4072, Queensland, Australia
| | - Norelle L. Daly
- Institute for Molecular Bioscience, The University of Queensland, St Lucia 4072, Queensland, Australia
| | - David J. Craik
- Institute for Molecular Bioscience, The University of Queensland, St Lucia 4072, Queensland, Australia
| | - Richard J. Lewis
- Institute for Molecular Bioscience, The University of Queensland, St Lucia 4072, Queensland, Australia
| | - Paul F. Alewood
- Institute for Molecular Bioscience, The University of Queensland, St Lucia 4072, Queensland, Australia
| |
Collapse
|
11
|
Pattabiraman VR, McKinnie SMK, Vederas JC. Solid-supported synthesis and biological evaluation of the lantibiotic peptide bis(desmethyl) lacticin 3147 A2. Angew Chem Int Ed Engl 2008; 47:9472-5. [PMID: 18937239 DOI: 10.1002/anie.200802919] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
12
|
Pattabiraman V, McKinnie S, Vederas J. Solid-Supported Synthesis and Biological Evaluation of the Lantibiotic Peptide Bis(desmethyl) Lacticin 3147 A2. Angew Chem Int Ed Engl 2008. [DOI: 10.1002/ange.200802919] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
13
|
Grieco P, Cai M, Liu L, Mayorov A, Chandler K, Trivedi D, Lin G, Campiglia P, Novellino E, Hruby VJ. Design and microwave-assisted synthesis of novel macrocyclic peptides active at melanocortin receptors: discovery of potent and selective hMC5R receptor antagonists. J Med Chem 2008; 51:2701-7. [PMID: 18412316 DOI: 10.1021/jm701181n] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Differentiation of the physiological role of the melanocortin receptor 5 MC5R from that of other melanocortin receptors will require development of high affinity and selective antagonists. To date, a few synthetic antagonist ligands active at hMC5 receptor are available, but most do not have appreciable selectivity. With the aim to gain more potent and selective antagonists for the MC5R ligands, we have designed, synthesized, and pharmacologically characterized a series of alkylthioaryl-bridged macrocyclic peptide analogues derived from MT-II and SHU9119. These 20-membered macrocycles were synthesized by a tandem combination using solid phase peptide synthesis and microwave-assisted reactions. Biological assays for binding affinities and adenylate cyclase activities for the hMC1R, hMC3R, hMC4R, and hMC5R showed that three analogues, compounds, 9, 4, and 7, are selective antagonists at the hMC5 receptor. In particular, compound 9(PG-20N) is a selective and competitive hMC5R antagonist, with IC 50 of 130 +/- 11 nM, and a pA 2 value of 8.3, and represents an important tool for further biological investigations of the hMC5R. Compounds 4 and 7 (PG14N, PG17N) show potent and selective allosteric inhibition at hMC5R with IC 50 values of 38 +/- 3 nM and 58 +/- 6 nM, respectively. Compound 9 will be used to further investigate and more clearly understand the physiological roles played by the MC5 receptor in humans and other animals.
Collapse
Affiliation(s)
- Paolo Grieco
- Department of Chemistry, University of Arizona, Tucson, Arizona 85721, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
|
15
|
Mohd Mustapa MF, Harris R, Esposito D, Chubb NAL, Mould J, Schultz D, Driscoll PC, Tabor AB. Synthesis of a Cyclic Peptide Containing Norlanthionine: Effect of the Thioether Bridge on Peptide Conformation. J Org Chem 2003; 68:8193-8. [PMID: 14535803 DOI: 10.1021/jo0346407] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Two diastereomeric analogues of ring C of nisin incorporating a novel norlanthionine residue have been synthesized via a triply orthogonal protecting group strategy. A full structural study was carried out by NMR, which elucidated the conformational properties of the two peptides and enabled the identity of each diastereoisomer to be proposed.
Collapse
Affiliation(s)
- M Firouz Mohd Mustapa
- Department of Chemistry, University College London, Christopher Ingold Laboratories, 20 Gordon Street, London WC1H OAJ, UK
| | | | | | | | | | | | | | | |
Collapse
|
16
|
Abstract
Constricting the peptide backbone into a more defined conformational form through cyclization is an activity evolved in nature and in synthetic work, the latter straddling only the most recent decades. The resulting conformational constraints increase the probability of an optimum response with bio-receptors. The purpose of this review is to highlight developments that have proved to be reasonably efficient in the macrocyclization of linear precursors into cyclic peptides and depsipeptides.
Collapse
Affiliation(s)
- John S Davies
- Department of Chemistry, University of Wales, Swansea, Singleton Park, Swansea SA2 8PP, UK.
| |
Collapse
|
17
|
Virta P, Katajisto J, Niittymäki T, Lönnberg H. Solid-supported synthesis of oligomeric bioconjugates. Tetrahedron 2003. [DOI: 10.1016/s0040-4020(03)00704-x] [Citation(s) in RCA: 62] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
18
|
|
19
|
Synthesis of cyclic peptides containing nor-lanthionine bridges via a triply-orthogonal protecting group strategy. Tetrahedron Lett 2002. [DOI: 10.1016/s0040-4039(02)01980-9] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
20
|
Swali V, Matteucci M, Elliot R, Bradley M. The stereospecific synthesis of ‘orthogonally’ protected lanthionines. Tetrahedron 2002. [DOI: 10.1016/s0040-4020(02)01091-8] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
21
|
Abstract
Fmoc-(2R,3S)-3-methyl-Se-phenylselenocysteine was used for the synthesis of dehydrobutyrine (Dhb)-containing peptides. Biomimetic cyclization via Michael addition of Cys to a Dhb yielded the B-ring of the lantibiotic subtilin as a single diastereomer. The methyllanthionine product was shown to have the natural configuration by preparation of the authentic stereoisomer. The formation of a single isomer suggests that the prepeptide has a strong intrinsic preference for the stereochemistry observed in lantibiotics. [reaction: see text]
Collapse
Affiliation(s)
- Hao Zhou
- Department of Chemistry, University of Illinois at Urbana-Champaign, 600 South Mathews Avenue, Urbana, IL 61801, USA
| | | |
Collapse
|
22
|
Magdolen V, Bürgle M, de Prada NA, Schmiedeberg N, Riemer C, Schroeck F, Kellermann J, Degitz K, Wilhelm OG, Schmitt M, Kessler H. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87). Biol Chem 2001; 382:1197-205. [PMID: 11592401 DOI: 10.1515/bc.2001.150] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Urokinase-type plasminogen activator (uPA) represents a central molecule in pericellular proteolysis and is implicated in a variety of physiological and pathophysiological processes such as tissue remodelling, wound healing, tumor invasion, and metastasis. uPA binds with high affinity to a specific cell surface receptor, uPAR (CD87), via a well defined sequence within the N-terminal region of uPA (uPA19-31). This interaction directs the proteolytic activity of uPA to the cell surface which represents an important step in tumor cell proliferation, invasion, and metastasis. Due to its fundamental role in these processes, the uPA/uPAR-system has emerged as a novel target for tumor therapy. Previously, we have identified a synthetic, cyclic, uPA-derived peptide, cyclo19,31uPA19-31, as a lead structure for the development of low molecular weight uPA-analogues, capable of blocking uPA/uPAR-interaction [Burgle et al., Biol. Chem. 378 (1997), 231-237]. We now searched for peptide variants of cyclo19,31uPA19-31 with elevated affinities for uPAR binding. Among other tasks, we performed a systematic D-amino acid scan of uPA19-31, in which each of the 13 L-amino acids was individually substituted by the corresponding D-amino acid. This led to the identification of cyclo19,31[D-Cys19]-uPA19-31 as a potent inhibitor of uPA/uPAR-interaction, displaying only a 20 to 40-fold lower binding capacity as compared to the naturally occurring uPAR-ligands uPA and its amino-terminal fragment. Cyclo19,31[D-Cys19]-uPA19-31 not only blocks binding of uPA to uPAR but is also capable of efficiently displacing uPAR-bound uPA from the cell surface and to inhibit uPA-mediated, tumor cell-associated plasminogen activation and fibrin degradation. Thus, cyclo19,31[D-Cys19]-uPA19-31 represents a promising therapeutic agent to significantly affect the tumor-associated uPA/uPAR-system.
Collapse
Affiliation(s)
- V Magdolen
- Frauenklinik der Technischen Universität München, Germany
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|